BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.9000
+0.2990 (49.75%)
At close: May 4, 2026

BFNH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.29-0.49-0.47-0.49-0.5
Other Operating Activities
0.8----
Change in Accounts Payable
00.010-0.010
Change in Other Net Operating Assets
0.420.420.420.420.42
Operating Cash Flow
-0.07-0.06-0.05-0.07-0.08
Short-Term Debt Issued
0.070.050.050.060.05
Total Debt Issued
0.070.050.050.060.05
Net Debt Issued (Repaid)
0.070.050.050.060.05
Issuance of Common Stock
-0.01-0-
Financing Cash Flow
0.070.060.050.060.05
Net Cash Flow
-00-0-0.01-0.03
Levered Free Cash Flow
-1.820.120.130.110.11
Unlevered Free Cash Flow
-1.820.120.130.110.11
Change in Working Capital
0.420.430.430.420.42
Source: S&P Global Market Intelligence. Standard template. Financial Sources.